Differential effects of selective beta-adrenergic blockade on insulin sensitivity and release in control subjects and in patients with angina and normal coronary arteries (syndrome X)

Giornale Italiano di Cardiologia

Volumn 28, Issue 6, 1998, Pages 623-629

  Fragasso, Gabriele ^a,b   Cattaneo, Nicoletta ^a   Locatelli, Massimo ^a   Caumo, Andrea ^a   Pagnotta, Paolo ^a   Piatti, Piermarco ^a   Bonini, Pierangelo ^a   Chierchia, Sergio L ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Angina pectoris; Syndrome X

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; ANGINA PECTORIS; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; FEMALE; GLUCOSE METABOLISM; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; SYNDROME X;

ADMINISTRATION, ORAL; ADRENERGIC BETA-ANTAGONISTS; ATENOLOL; BLOOD GLUCOSE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EXERCISE TEST; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MICROVASCULAR ANGINA; MIDDLE AGED; TIME FACTORS;

EID: 0031778634     PISSN: 00465968     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. ROMEO F, GASPARDONE A, CIAVOLELIA M, GIOFFRÈ P, REALE A Verapamil vs acebutolol for syndrome X Am J Cardiol 1988; 62: 312-313.
2. BUGIARDINI R, BORGHI A, BIAGETTI L, PUDDU P. Comparison of verapamil vs propranolol therapy in syndrome X Am J Cardiol 1989, 63: 266-290
3. FRAGASSO G, CHIERCHIA S, PIZZETTI G, ET AL Impaired left ventricular filling dynamics in patients with angina and angiographically normal coronary arteries effect of beta-adrenergic blockade Heart 1997, 77 32-39
4. POLLARE T, LITHELL H, MORLIN C, PRANTARE H, HVARFNER A, LRUNGHALL S. Metabolic effects of diltiazem and atenolol results from a randomized, double blind study with parallel groups J Hypertens 1989, 7: 551-559.
5. DEAN JD, JONES CHJ, HUTCHINSON SJ, PETERS JR, HENDERSON AH Hyperinsulinemia and microvascular angina (syndrome X). Lancet 1991; 337 456-457
6. BOTKER HE, MOLLER N, OVESEN P, MENGEL A, SCHMITZ O, ORSKOV H: Insulin resistance in microvascular angina (syndrome X) Lancet 1993, 342 136-140
7. SWAN JW, WALTON C, GODSLAND IF, CROOK D, OLIVER MF, STEVENSON JC: Insulin resistance syndrome as a feature of cardiological syndrome X in non-obese men. Br Heart J 1994; 71: 41-44
8. CHAUHAN A, FOOTE J, PETCH MC, SCHOFIELD PM Hyperinsulinemia, coronary artery disease and syndrome X J Am Coll Cardiol 1994, 23: 364-368
9. REAVEN GM, LITHELL H, LANDSBERG L Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system N Engl J Med 1996; 334: 374-381
10. BERGMAN RN, IDER YZ, BOWDEN CR, COBELLI C Quantitative estimation of insulin sensitivity. Am J Physiol 1979, 236: E667-E677
11. BERGMAN RN, PRAGER R, VOLUND A, OLEFSKY JM. Equivalence of the insulin sensitivity index in man derived by the minimal model and the euglycemic glucose clamp J Clin Invest 1987; 79: 790-800.
12. CAUMO A, GIACCA A, MORGESE M, POZZA G, MICOSSI P, COBELLI C Minimal model of glucose disappearance; lessons from the labelled IVGTT. Diab Med 1991; 8: 822-832.
13. SAAD MF, ANDERSON RL, LAWS A, ET AL A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance Diabetes 1994, 43: 1114-1121
14. FAGERBERG B, BERGLUND A, HOLME E, WILHELMSEN L, ELMFELDT D Metabolic effects of controlled-release metoprolol in hypertensive men with impaired or diabetic glucose tolerance a comparison with atenolol J Intern Med 1990 227: 37-43
15. STARKE AR, HEINEMANN L, AMPUDIA J Keine Beeinflussung der Insulinsensitivitat durch ACE-Hemmer oder kardioselektive Beta Blocker (abstract) Diabetes Stoffw 1993; 2: 194-195
16. POLLARE T, LITHELL H, SELINUS I, BERNE C. Sensitivity to insulin during treatment with atenolol and metoprolol a randomized, double-blind study of effects of carbohydrate and lipoprotein metabolism in hypertensive patients Br Med J 1989, 298: 1152-1157
17. ROSANO GMC, PONIKOWSKI P, ADAMOPOULOS S, ET AL: Abnormal autonomic control of the cardiovascular system in syndrome X Am J Cardiol 1994, 73: 1174-1179.
18. LEONARDO F, FRAGASSO G, ROSANO GMC, PAGNOTTA P, CHIERCHIA SL: Effect of atenolol on QT interval and dispersion in patients with syndrome x Am J Cardiol 1997; 80 789-790
19. MONTORSI P, MANFREDI M, LOALDI A, ET AL: Comparison of coronary vasomotor responses to nifedipine in syndrome X and in Prinzmetal's angina pectoris Am J Cardiol 1989, 63 1198-1202
20. BUGIARDINI R Epicardial coronary artery reactivity in patients with syndrome X: the role of increased adrenergic tone Cor Art Dis 1992, 3: 547-554
21. JULIUS S: Corcoran Lecture Sympathetic hyperactivity and coronary risk in hypertension Hypertension 1993, 21: 886-893
22. JULIUS S, GUDBRANDSSON T, JAMERSON K, TARIK SHAHAB S, ANDERSSON O The hemodynamic link between insulin resistance and hypertension J Hypertens 1991, 9: 983-986
23. DEIBERT DC, DE FRONZO RA Epinephrine-induced insulin resistance in man J Clin Invest 1980; 65 717-721
24. FRAGASSO G, CHIERCHIA SL, ROSSETTI E, LANDONI C, LUCIGNANI G, FAZIO F Abnormal myocardial glucose handling in patients with syndrome x effect of beta-adrenergic blockade G Ital Cardiol 1997, 27: 1113-1120
25. MONTI LD, LUCIGNANI G, LANDONI C, ET AL: Myocardial glucose uptake evaluated by positron emission tomography and fluorodeoxyglucose during hyperglycemic clamp in IDDM patients. Role of free fatty acid and insulin level Diabetes 1995, 44 537-542.
26. PIATTI PM, MONTI LD, PACCHIONI M, PONTIROLI AE, POZZA G Forearm insulin- and non-insulin-mediated glucose uptake and muscle metabolism in man role of free fatty acids and blood glucose uptake Metabolism 1991, 40 926-933